United States: Food, Drugs, Healthcare, Life Sciences

AI licensing in healthcare involves complex decisions about asset definition, control allocation, and accountability as models and data evolve. This white paper examines the practical contracting challenges that arise when AI models intersect with health data, exploring how organizations can structure agreements that account for messy datasets, model artifacts, and the reality that machine learning systems resist traditional ownership frameworks.

This digest covers key virtual and digital health regulatory and public policy developments during March and early April 2026 from the United States, United Kingdom, and European Union.

On March 30, 2026, the U.S. Department of the Treasury (the Treasury) Financial Crimes Enforcement Network (FinCEN) issued an Advisory urging financial institutions to step up their detection and reporting of suspicious transactions tied to Medicare, Medicaid, and other healthcare benefit program fraud schemes.